Rivaara Labs

Rivaara Labs Rivaara Labs is an exclusive lab chain for molecular diagnostics in India.

07/05/2026

Empirical antibiotics remain crucial in critical infections—but when patients fail to improve, identifying the exact pathogen quickly becomes equally important.
Dr. Kusum Sikariya shares a real-world meningitis case where rapid PCR-based testing helped detect the causative pathogen and supported a shift toward more targeted treatment.
This case highlights the growing importance of molecular diagnostics in supporting faster clinical decision-making in ICU and neuro-critical care settings.

11/04/2026

Sepsis continues to be a race against time—where early, informed decisions can significantly impact patient outcomes.

In this testimonial, Dr. Nikhil Varge (Intensivist Faculty) presents a real-world sepsis case, detailing the patient’s clinical condition and the challenges faced in early diagnosis and management. He highlights how the Rivaaras SeptiQuik Panel enabled rapid pathogen identification along with antimicrobial resistance (AMR) insights, facilitating timely, targeted therapy.

This case underscores the growing importance of rapid molecular diagnostics in critical care—especially in the face of rising AMR.

Watch the full video to gain practical clinical insights.

Every Hour Counts in Pediatric Sepsis ⏳In India, sepsis continues to be a silent emergency—especially among our youngest...
10/04/2026

Every Hour Counts in Pediatric Sepsis ⏳
In India, sepsis continues to be a silent emergency—especially among our youngest patients.
🔬 Over 1 lakh cases reported annually
👶 Nearly 40% affect children under 5
⚠️ Newborns remain at the highest risk
💔 Severe cases can see mortality rates as high as 30–35%
With rising antimicrobial resistance, first-line treatments are becoming less effective—making early, accurate diagnosis more critical than ever.
At Rivaara Labs, we believe timely molecular diagnostics can help clinicians move from uncertainty to precision—saving lives when it matters most.
👉 Because in pediatric sepsis, survival should depend on certainty, not chance.

17/03/2026

When Every Hour Matters in Sepsis ⏱️

In a real-world case, Dr. Jithesh Gangadharan, EMS hospital, Kerala, highlights how rapid identification of the causative pathogen and AMR gene using Rivaara Labs’ SeptiQuik Panel supported timely, targeted clinical decisions in a critical sepsis patient.
With rising antimicrobial resistance (AMR) complicating outcomes, early molecular insights are no longer optional—they are essential.

SPOT SEPSIS. STOP SEPSIS.

Superbugs are rising, and antibiotics are losing their effectiveness.ICMR insights highlight a growing burden of drug-re...
16/02/2026

Superbugs are rising, and antibiotics are losing their effectiveness.

ICMR insights highlight a growing burden of drug-resistant infections, especially in critical care. Early and precise diagnosis is now essential to guide targeted therapy and improve patient outcomes.

At Rivaara Labs, we are committed to enabling clinicians with advanced molecular diagnostics to support faster, evidence-based treatment decisions.

Because today’s infection should never become tomorrow’s untreatable disease.

This Republic Day, we celebrate the spirit of India and our shared responsibility to build a healthier nation.At Rivaara...
25/01/2026

This Republic Day, we celebrate the spirit of India and our shared responsibility to build a healthier nation.

At Rivaara Labs, we remain committed to advancing molecular diagnostics that support timely, precise, and responsible clinical care.

🇮🇳 Happy Republic Day!

13/01/2026

AMR: From National Concern to Clinical Action

In a recent Mann Ki Baat, Hon’ble Prime Minister Shri Narendra Modi highlighted a growing threat to public health — common infections are becoming harder to treat as antibiotics lose effectiveness, citing data generated by ICMR’s national AMR surveillance.

This is a crucial reminder that AMR is not a future risk — it is a present clinical reality, especially in infections such as pneumonia, UTIs, sepsis, and ICU-associated infections.

At RIVAARA, we believe antimicrobial stewardship begins with the laboratory.

Timely, accurate diagnostic insights can help:
Identify the true causative pathogen
Detect key resistance mechanisms early
Reduce unnecessary empirical antibiotic escalation
Support evidence-based, targeted therapy.

Our diagnostic panels are designed to support clinicians in making faster, informed treatment decisions, aligning with national AMR containment goals outlined by ICMR.

🔬 Right diagnosis → Right antibiotic → Right time

This is how laboratories and clinicians can work together to preserve the effectiveness of antibiotics for future generations.

11/01/2026

SPOT SEPSIS. STOP SEPSIS.

Post-transplant sepsis remains one of the most critical challenges in clinical care—made even more complex by India’s high burden of antimicrobial resistance (AMR).

Over 30% of sepsis-related deaths in India are linked to antibiotic resistance, posing a serious risk in post-transplant patients, where timely and precise decisions are crucial.

In this testimonial, Dr. Rahul Kendre (Transplant Physician, Dr. D. Y. Patil Hospital, Pune) shares key learnings from a real-world post-transplant sepsis case, highlighting how early and accurate pathogen & resistance detection can help reduce unnecessary broad-spectrum antibiotic use and support better outcomes.

At Rivaara Labs, we are committed to supporting clinicians with rapid molecular diagnostics that enable timely, targeted therapy and stronger antimicrobial stewardship—when every hour matters.

04/01/2026

Cervical cancer is preventable—if detected early
So,Screen Early, Screen Right.

As global awareness efforts kick off (Jan 1–7, 2026), this testimonial from Dr. Priti Vyas reinforces why HPV + LBC co-testing is critical for effective cervical cancer screening.

Rivaaras HPV & LBC testing services are helping clinicians make screening more impactful during this global awareness drive.

HPV + LBC co-testing enables earlier detection, better clinical decisions, and better outcomes for women.

Rivaaras is proud to support this mission.

Address

17th Floor, Hoechst House, Nariman Point
Mumbai
400021

Telephone

+919301000083

Website

Alerts

Be the first to know and let us send you an email when Rivaara Labs posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Rivaara Labs:

Shortcuts

Share

Category